What GLP-1 receptor agonists are used for FDA-approved indications across the class include type 2 diabetes (most compounds), chronic weight management (Wegovy, Saxenda, Zepbound), cardiovascular risk reduction in type 2 diabetes (several products), and obstructive sleep apnea in adults with obesity (Zepbound, 2024)
Headache Vyvanse may cause headaches in some people who take this drug
It can also help you get through a busy morning without worrying whether you might feel queasy during an early meeting or commute
Q9: What happens if I miss a retatrutide dose
Using similar BMI cutpoints for semaglutide 2.4 mg in the STEP 1 trial, there was an overall 15.3 kg weight loss corresponding to a 14.9% reduction, with 88.4% and 69.1% showing weight reductions of at least 5% and 10%, respectively [9]